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Effect of Psychotropic Medication on Foster Care Experience and
Outcomes: A Causal Analysis using Administrative Data
Abstract
Children in foster care experienced abuse, neglect, or dependency, and for the safety and well-being of the
child, must be taken out of their biological home. Not surprisingly, children in foster care have higher rates of
serious emotional and behavioral problems. Although pharmacological treatments can be an important
component of the treatment plan, there seems to be a higher rate of use than would be expected. An estimated
13-25% of foster children are prescribed mind- and mood-altering medication vs. 4% in the general
population.
Children in foster care are considered a vulnerable population and research involving these children justifiably
requires additional measures to ensure their protection. As a result, studies on the use of psychotropic
medication among youth in foster care have relied primarily on secondary data‚ typically administrative data.
This study used linked administrative datasets to rigorously examine the effect of psychotropic medication on
foster care experiences and outcomes among children who entered foster care in North Carolina between
March 2006 and June 2012. The dataset was constructed by linking the North Carolina’s child welfare
administrative records (also known as the Services Information System [SIS]) with the Medicaid claims
database (also known as the Eligibility Information System [EIS]) for medical and mental health services
received by the foster youth. Inverse probability of treatment weighting was calculated and applied to mimic a
randomized study. Results revealed that children on medication stayed in care longer, less likely to experience
placement disruption, and more likely to exit to adoption.
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Foster Care Experience and Outcomes: 
A Causal Analysis using Administrative Data
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Introduction
On any given day, approximately 400,540
children in foster care in the US  1, 2 
Trauma Experienced
Abuse or 
Neglect Homelessness
Exposure to 
domestic 
violence
Exposure to 
substance 
abuse
Multiple 
placements
Loss of 
Control
Introduction
• 50-80% of children have moderate to severe 
mental health problems 3, 4, 5
• Many prescribed psychotropic medication 
(reports ranging from 20% to 40%) 6
• Children in foster care more likely to be 
prescribed psychotropic medication (2.7 to 4.5 
times the rate of non-foster youth)  6, 8
What are psychotropic medications?
Psychotropic medications are medicine capable of 
affecting the mind, emotions, and behavior; denoting 
drugs used in the treatment of mental illness.
Psychotropic medications 6,7
Stimulants Treats: ADD/ADHD
Strattera, Vyvanse, Ritalin, 
Concerta, Adderall, Dexedrine, 
Dextrostat
Adverse effects: Decreased appetite, tics, psychosis, 
flat effect, difficulty sleeping
Antianxiety Treats: Generalized anxiety disorder, PTSD, social 
phobias
Klonopin, Ativan, Xanax Adverse effects: Dependence, drowsiness and 
dizziness, blurred vision, nightmares, headaches
Antidepressants Treats: Depression, anxiety, OCD, social phobia
Prozac, Celexa, Zoloft, Paxil, 
Lexapro, Effexor, Cymbalta, 
Wellbutrin
Adverse effects: Suicidal thoughts, sleeplessness or 
drowsiness, agitation, sexual dysfunction, Weight 
gain, nausea and vomiting
Psychotropic medications (cont.) 6, 7
Antipsychotics Treats: bipolar disorder, schizophrenia, Tourette’s 
syndrome
Thorazine, Haldol, Risperdal, 
Zyprexa, Seroquel, Geodon, 
Abilify
Adverse effects: rigidity, tremor, tardive dyskinesia, 
diabetes, high cholesterol, weight gain, neuroleptic 
malignant syndrome
Mood stabilizers Treats: Bipolar disorder, depression
Lithium, Depakote, Tegretol, 
Lamcital, Trileptal
Adverse effects: suicidal thoughts; loss of 
coordination; hallucinations; kidney, thyroid, liver 
and pancreatic damage; polycystic ovarian 
syndrome; weight gain
Alpha-adrenergic 
agonists (AAAs)
Treats: ADD/ADHD, insomnia and sleep problems, 
PTSD
Clonidine, guanfacine Adverse effects: Sedation, headache, excitability, 
restlessness
Problem Statement
Concern 1: Off-Label Use
• These medications are often “off-label” 
• Off-Label: 
– Untested for efficacy and safety in pediatric 
populations or indication 9
– Different dosage than approved for an indication 
by the FDA
Problem Statement
Concern 2: Side Effects
Host of negative side-effects 11
• Weight gain and metabolic changes
• Sedation
• Low blood pressure (Orthostatic Hypotension)
• Abnormally rapid heart rate (Tachycardia)
• Menstrual problems
• Blurred vision
• Skin rashes
• Sun sensitivity
Problem Statement
Concern 3: Lack of Oversight
• Children in foster care are particularly 
vulnerable due to lack of oversight by 
caretaker and agency 6
• One study found that 34 of 48 states had not 
implemented a system to identify 
prescriptions with dosages exceeding current 
recommended maximum recommendations 5
Gap in Research
• Children in foster care are a particularly vulnerable population 
with high need and high rates of psychotropic medication
• Research in this area have only covered the prevalence rates 
of  psychotropic medication thus far
• Few studies conducted beyond descriptive analysis that look 
at long-term causal effects of medication use
• More research is needed to understand the  short- and long-term 
effects of foster youth receiving psychotropic medication
• Placement types
• Placement changes
• Exit type
• Health
• Educational
• Behavioral
• Social
Rigorous research challenging with foster youth: 
need innovative statistical techniques to take 
advantage of existing administrative data
Outcome Measures
Since the passage of the Adoption and Safe Families Act of 1997, 
the U.S. Department of Health and Human Services has 
established several important objectives and outcomes of 
interest that relate to the safety and well-being of children in 
foster care:
Length of 
Time in Care
Placement 
Stability Permanency
Research Questions
1. How does medicating children in foster care 
effect how long they are in care?
2. How does medicating children in foster care 
effect placement stability?
3. How does medicating children in foster care 
effect how they exit to permanency?
Methods Overview
Data management
Propensity score analysis (IPTW)
Outcome analysis
Causal Analysis
Potential Outcomes Model
M
E
T
H
O
D Yi (0)
Yi (1)
!" = $% 1 − $%(0)
Causal effect is the difference between the potential 
outcome that would arise for an individual under 
two different treatment/exposure conditions1
Criteria for Causality2
• X precedes Y
• X is related to Y
• No plausible alternative explanations for Y exist other 
than X
M
E
T
H
O
D
Yi (1)
Confounders
Causal Analysis:
Random Assignment vs. Observational Study
M
E
T
H
O
D
Propensity Score Analysis
• PSA increasingly used to use observational studies to 
estimate treatment effects and outcomes 3
• Reduces the effect of confounding due to differences in 
the distribution of measured baseline characteristics 
between treatment groups
• PSA mimics randomized treatment groups by comparing 
outcomes in treated and untreated subjects who have a 
similar distribution of measured baseline covariates
M
E
T
H
O
D
Propensity Score (e)
A propensity score is a conditional probability of 
being assigned (or selected) to a treatment group 4
!" = Pr &" = 1 ("
M
E
T
H
O
D
Treatment Group
(e.g., Medication)
Baseline covariates
Propensity Score Analysis Methods
Four methods of using propensity scores 5
1. Propensity score matching
2. Stratification on the propensity score
3. Inverse probability of treatment weighting 
(IPTW) using the propensity score
4. Covariate adjustment using the propensity 
score
M
E
T
H
O
D
Inverse Probability of Treatment 
Weighting (IPTW)
üSurvival outcomes
üMore complex study designs and research 
questions (e.g., time-varying confounders)
üNo loss of sample (like matching and 
stratification)
M
E
T
H
O
D
Types of Treatment Effect
M
E
T
H
O
D
• Average Treatment Effect (ATE)
– Treatment effect for the overall target population in the study 
(treated and untreated subjects together)
• Average Treatment Effect among the Treated (ATT)
– Treatment effect for the treated subjects only
Inverse Probability of Treatment 
Weighting (IPTW)
M
E
T
H
O
D
• Estimated propensity scores were inverted to create 
IPTWs !"#$ = &' + 1 − &1 − '
• Very large weights can cause instability: therefore 
stabilize weights by multiplying the IPTW by the marginal 
probability of receiving the actual treatment received !"#$,,#"- = Pr & = 1 &' + Pr(& = 0) 1 − &1 − '
• Trim weights to 5th and 95th percentile
Steps to Propensity Scoring
M
E
T
H
O
D
Steps Method
1. Create weights on probability of 
being in medication treatment group 
based on variables from prior 
knowledge
• Logistic regression with 
logit link
• Invert to IPTWs
• Stabilize weights
• Truncate extreme 
weights
2. Assess weight distributions and 
overlap
• Histogram
• Box-plot
3. Assess balance of baseline covariates 
before and after weighting
• Standardized mean 
differences
Outcome Analysis
M
E
T
H
O
D
Outcome Analysis
1. Time to permanency Cox proportional hazards 
regression model with IPTW
2. Placement stability Poisson count regression 
with IPTW
3. Exit to permanency Multinomial logistic 
regression with IPTW
Outcome Analysis
1. Time to Permanent Exit
M
E
T
H
O
D
Weighted Cox Proportional Hazards Model with 
time-varying variableslogℎ% & = ( & + *+,%+ + *-,%-(&)
Outcome Analysis
2. Placement Stability
M
E
T
H
O
D
Poisson Count Regression exposure (time) offset
where
y = dependent variable (count)
E(y) = Expected count value
x = Independent variables
b0, b1 are regression coefficients
t = time period observed (exposure)
Log(t) is the offset variable
log $(&) = )* + ),- + ),-(.) + log(./012345/)
Outcome Analysis
3. Exit type
M
E
T
H
O
D
Weighted multinomial logistic regression with 
time-varying covariates
For m=2, …M (outcomes)
! "# = % = exp(*+#)1 + ∑0123 exp(*0#)
For reference category,! "# = 1 = 11 + ∑0123 exp(*0#)
Literature Review: 
Predictors of Psychotropic Medication Use Among Foster Youth
Significant Non-Significant
• Older 1, 2, 3, 5, 6, a
• Physical abuse 1, 2, 3
• White 1, 2, 3, 4, 5, b
• Male 1, 2, 3, 6
• Poor health 1, 2, 3
• Group home/out-of-home 
placement 1, 2, 3, 4, 5, b
• Externalizing behavior 1, 2, 3, 4
• Internalizing behavior 2, 3, c
• Abandonment 1, 2, 3, 6
• Sexual 1, 3, 6, d
• Neglect 1, 2, 3, 6
• Hispanic/Other (Ref. White) 1, 2, 3
• Pediatrician/psychiatrist ratio 6
• Rurality 1, 2, 3
• Time in placement or instability 5
Data Management
• Linked foster care administrative dataset with Medicaid 
claims dataset using unique id
• Inclusion Criteria: Children entered into the North 
Carolina foster care system between March 1, 2006 and 
June 30, 2012
• If < 7 days between spells, spells were combined
• First spell only
• Excluded very young children (< 5 years of age)
• Excluded children with severe, psychotic disorders
M
E
T
H
O
D
Measures
• Psychotropic Medication*
• Gender (Male/Female)
• Race/Ethnicity
– White (non-Hispanic)
– Black (non-Hispanic)
– Hispanic
– Other/Mixed
• Age* (0-4, 5-9, 10-14, 15-19)
• Abuse History
– Physical abuse
– Sexual Abuse
– Neglect 
– OtherM
E
T
H
O
D
• Placement Type*
– Foster care
– Therapeutic foster care
– Kinship care
– Residential care
– Other
• Entry cohort
• Physical Disability
• Parent substance abuse
• Single parent household
• Rurality
• Diagnosis*
• Number of Months in Care *
* Time-Varying
Measures
Psychotropic Medication
M
E
T
H
O
D
1. Antidepressants
2. Antipsychotics
3. Moodstabilizers
4. Anxiolytic
5. Stimulants
6. Alpha-adrenergic agonist (AAA)
Measures
Diagnosis
M
E
T
H
O
D
1. Schizophrenia and other psychoses
2. Pervasive developmental disorders and mental retardation (PDD-
MR)
3. Bipolar disorder
4. Disruptive disorders
5. Attention-deficit hyperactivity disorder (ADHD)
6. Depression disorders
7. Anxiety disorders
8. Adjustment disorder
9. Communication or learning disorders
10. Any other psychiatric diagnosis
IPTW Distribution
R
E
S
U
L
T
S
Balance Assessment
R
E
S
U
L
T
S
    Standardized Difference 
 
Unmedicated 
(n=10,250a) 
Medicated 
(n=4,529b) 
 Original 
Sample  
Weighted 
Sample 
Gender       
     Male (ref. Female) 4,670 (45.6%) 2,521 (55.7%)  0.20  0.04 
Race       
     White 4,765 (46.5%) 2,512 (55.5%)  0.18  0.02 
     Black 3,770 (36.8%) 1,451 (32.0%)  0.10  0.00 
     Hispanic 928 (9.1%) 251 (5.5%)  0.15  0.04 
     Other 787 (7.7%) 315 (7.0%)  0.03  0.01 
Age at Entry       
     5 to 9 years 4,416 (43.1%) 1,650 (36.4%)  0.14  0.03 
     10 to 14 years 3,447 (33.6%) 1,706 (37.7%)  0.08  0.01 
     15 to 19 years 2,387 (23.3%) 1,173 (25.9%)  0.06  0.03 
Physical Disability 43 (0.4%) 45 (1.0%)  0.06  0.01 
Parent       
     Substance abuse 2,893 (28.2%) 1,244 (27.5%)  0.02  0.01 
     Single parent 6,117 (59.7%) 2,694 (59.5)  0.00  0.01 
Placement       
     Foster care 3,668 (35.8%) 1,637 (36.1%)  0.01  0.01 
     Therapeutic foster care 353 (3.4%) 366 (8.1%)  0.17  0.03 
     Group care 1,054 (10.3%) 748 (16.5%)  0.17  0.04 
     Kinship care 3,388 (33.1%) 1,068 (23.6%)  0.22  0.05 
     Other 1,787 (17.4%) 710 (15.7%)  0.05  0.01 
Abuse History       
     Physical abuse 783 (7.6) 377 (8.3%)  0.02  0.00 
     Sexual abuse 595 (5.8%) 277 (6.1%)  0.01  0.00 
     Neglect 7,838 (76.5%) 3,320 (73.3%)  0.07  0.02 
     Other 2,111 (20.6%) 1,063 (23.5%)  0.07  0.02 
Diagnosis 1774 (17.3%) 2,418 (53.4%)  0.72*  0.04 
     Disruptive disorder 683 (6.7%) 1,100 (24.3%)  0.41*  0.08 
     ADHD 240 (2.3%) 790 (17.4%)  0.40*  0.20 
     Depressive disorders 138 (1.3%) 174 (3.8%)  0.13  0.00 
     Anxiety disorders 137 (1.3%) 100 (2.2%)  0.06  0.08 
     Adjustment disorder 305 (3.0%) 113 (2.5%)  0.03  0.28* 
     Other mental disorders 8,476 (82.7%) 141 (3.1%)  0.03  0.20 
Entry cohort (median) 2008 2008  0.05  0.04 
Rurality       
     Urban (ref. Rural) 7,373 (71.9%) 3,335 (73.6%)  0.04  0.01 
*Standardized effect sizes in absolute values greater than 0.25 
a 69.4% of total sample  
b 30.6% of total sample 
Note. ADHD = Attention deficit and hyperactivity disorder.  
The weighted sample was constructed on the standardized inverse-probability of the treatment weighted 
(IPTW) 
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Descriptive Data (Raw)
R
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Outcome
Medicated
(n=4,529)
Non-Medicated
(n=10,2507)
Length of Time in Care
Mean (SE; in months) 8.6 (0.17) 9.7 (0.12)
Placement Stability
Average number of placements (SD) 4.8 (5.2) 2.8 (3.6)
Exit Type
Reunification 1,650 (36.4%) 4,178 (40.8%)
Adoption 692 (15.3%) 1,344 (13.1%)
Guardianship 1,126 (24.9%) 3,072 (30.0%)
No Permanency 1,061 (23.4%) 1,656 (16.2%)
Outcome 1: Length of Time
Survival Analysis
R
E
S
U
L
T
S
Outcome 1: Length of Time
Cox Regression
R
E
S
U
L
T
S
Variable Hazard Ratio (95% CI) p value 
Medication  0.40 (0.37-0.41) < .0001 
   
Gender   
    Male (ref. Female) 0.99 (0.96-1.04) NS 
Average age 1.01 (1.01-1.02) < .001 
Race   
    Black (ref. White) 1.11 (1.06-1.16) < .0001 
    Hispanic (ref. White) 0.99 (0.92-1.07) NS 
    Other (ref. White) 1.13 (1.04-1.22) < .01 
MH diagnosis   
     Disruptive disorder 0.93 (0.87-0.98) <.05 
     ADHD 0.94 (0.88-1.00) NS 
     Depressive disorders 1.00 (0.90-1.10) NS 
     Anxiety disorders 0.93 (0.83-1.03) NS 
     Adjustment disorder 1.03 (0.94-1.14) NS 
     Other mental disorders 0.88 (0.78-0.98) <.05 
Physical disability 1.01 (0.77-1.31) NS 
Placement   
    Foster care 1.95 (1.82-2.08) < .0001 
    Therapeutic foster care 1.82 (1.69-1.96) < .0001 
    Kinship care 0.97 (0.90-1.04) NS 
    Group home 1.45 (1.34-1.57) < .0001 
    Other - - 
Abuse   
    Physical 1.11 (1.04-1.19) < .01 
    Sex 1.20 (1.10-1.30) < .0001 
    Neglect 1.08 (0.96-1.22) NS 
    Other 1.09 (0.96-1.23) NS 
Parental characteristics   
    Substance abuse 0.98 (0.94-1.03) NS 
    Single parent 1.05 (1.01-1.09) <.05 
Entry cohort 2.03 (2.00-2.06) < .0001 
Metropolitan 0.99 (0.95-1.04) NS 
Number of placement changes 0.51 (0.50-0.52) < .0001 
Event and censored values:   
    Events: 12,049   
    Censored: 40,083   
    Total: 52,132   
    % Censored: 76.89   
   
 Without 
covariates 
With covariates Model chi-square df p 
-2 log L 167,004.03 149,710.00 17,294.05 26 <.0001 
Note. ADHD = Attention-deficit hyperactivity disorder; CI = Confidence interval; NS = Non-
significant; ref. = Reference. 
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covariates 
With covariates Model chi-square df p 
-2 log L 167,004.03 149,710.00 17,294.05 26 <.0001 
Note. ADHD = Attention-deficit hyperactivity disorder; CI = Confidence interval; NS = Non-
significant; ref. = Reference. 
 
Variable Hazard Ratio (95% CI) p value 
Medication  0.40 (0.37-0.41) < .0001 
   
Gender   
    Male (ref. Female) 0.99 (0.96-1.04) NS 
Average age 1.01 (1.01-1.02) < .001 
Race   
    Black (ref. White) 1.11 (1.06-1.16) < .0001 
    Hispanic (ref. White) 0.99 (0.92-1.07) NS 
    Other (ref. White) 1.13 (1.04-1.22) < .01 
MH diagnosis   
     Disruptive disorder 0.93 (0.87-0.98) <.05 
     ADHD 0.94 (0.88-1.00) NS 
     Depressive disorders 1.00 (0.90-1.10) NS 
     Anxiety disorders 0.93 (0.83-1.03) NS 
     Adjustment disorder 1.03 (0.94-1.14) NS 
     Other mental disorders 0.88 (0.78-0.98) <.05 
Physical disability 1.01 (0.77-1.31) NS 
Placement   
    Foster care 1.95 (1.82-2.08) < .0001 
    Therapeutic foster care 1.82 (1.69-1.96) < .0001 
    Kinship care 0.97 (0.90-1.04) NS 
    Group home 1.45 (1.34-1.57) < .0001 
    Other - - 
Abuse   
    Physical 1.11 (1.04-1.19) < .01 
    Sex 1.20 (1.10-1.30) < .0001 
    Neglect 1.08 (0.96-1.22) NS 
    Other 1.09 (0.96-1.23) NS 
Parental characteristics   
    Substance abuse 0.98 (0.94-1.03) NS 
    Single parent 1.05 (1.01-1.09) <.05 
Entry cohort 2.03 (2.00-2.06) < .0001 
Metropolitan 0.99 (0.95-1.04) NS 
Number of placement changes 0.51 (0.50-0.52) < .0001 
Event and censored values:   
    Events: 12,049   
    Censored: 40,083   
    Total: 52,132   
    % Censored: 76.89   
   
 Without 
covariates 
With covariates Model chi-square df p 
-2 log L 167,004.03 149,710.00 17,29 .05 26 <.0001 
Note. ADHD = Attention-deficit hyperactivity disorder; CI = Confidence interval; NS = Non-
significant; ref. = Reference. 
 
Outcome 2: Placement Stability
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E
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   Wald 95% CI   
Characteristic B Std. 
Error 
Lower Higher  Incidence Rate 
Ratio 
Medication  -0.19*** 0.02 -0.23 -0.15  0.83 
       
Male       
    Male (ref. Female) 0.02 0.02 -0.02 0.06  1.02 
Age of Entry 0.03*** 0.00 0.02 0.03  1.03 
Race       
    Black (ref. White) -0.03 0.02 -0.07 0.02  0.97 
    Hispanic (ref. White) -0.10** 0.04 -0.17 -0.03  0.90 
    Other (ref. White) 0.01 0.04 -0.06 0.09  1.01 
MH diagnosis 0.22*** 0.02 0.18 0.26  1.25 
Physical disability -0.04 0.11 -0.26 0.18  0.96 
Placement       
    Foster care 0.14*** 0.02 0.10 0.19  1.15 
    Therapeutic FC 0.29*** 0.03 0.24 0.35  1.34 
    Kinship care 0.01 0.02 -0.04 0.05  1.01 
    Group home 0.27*** 0.03 0.22 0.32  1.31 
    Other       
Abuse       
    Physical 0.02 0.04 -0.05 0.09  1.02 
    Sex -0.02 0.04 -0.10 0.06  0.98 
    Neglect 0.01 0.06 -0.11 0.12  1.01 
    Other 0.05 0.06 -0.07 0.17  1.05 
Parents       
    Substance abuse -0.07*** 0.02 -0.12 -0.03  0.93 
    Single parent 0.02 0.02 -0.02 0.06  1.02 
Entry Cohort 0.06*** 0.01 0.05 0.07  1.06 
Metro -0.01 0.02 -0.06 0.03  0.99 
Note.  FC = Foster care; MH = Mental health; ref. = Reference.  
* p ≤ .05; ** p  ≤ .01.; *** p  ≤ .001 
 
Outcome 3: Exit Type
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Characteristic 
Reunification v. No 
permanency  
Guardianship v.  
No permanency  
Adoption v. No 
permanency 
OR (95% CI)   OR (95% CI)   OR (95% CI)  
Medication  0.50 (0.43-0.58) ***  0.59 (0.50-0.70) ***  1.03 (0.85-1.25)  
         
Male          
    Male (ref. Female) 1.06 (0.88-1.28)   1.08 (0.88-1.32)   0.85 (0.66-1.09)  
Age of entry 0.74 (0.72-0.76) ***  0.73 (0.71-0.76) ***  0.58 (0.56-0.61) *** 
Race         
    Black (ref. White) 0.65 (0.53-0.79) ***  0.75 (0.60-0.93) *  0.72 (0.55-0.94) * 
    Hispanic (ref. White) 0.62 (0.43-0.88) **  0.75 (0.49-1.14)   0.75 (0.49-1.15)  
    Other (ref. White) 0.84 (0.57-1.24)   0.92 (0.59-1.41)   1.02 (0.62-1.68)  
MH diagnosis          
     Disruptive disorder 0.78 (0.68-0.90) ***  0.69 (0.59-0.81) ***  0.74 (0.60-0.91) ** 
     ADHD 0.88 (0.70-1.10)   0.97 (0.77-1.22)   1.17 (0.90-1.53)  
     Depressive disorder 0.84 (0.65-1.08)   0.96 (0.73-1.28)   1.08 (0.69-1.70)  
     Anxiety 1.07 (0.79-1.43)   0.81 (0.58-1.13)   1.70 (1.23-2.34) ** 
     Adjustment 0.87 (0.71-1.07)   0.97 (0.78-1.20)   1.13 (0.89-1.45)  
     Other 1.05 (0.81-1.35)   1.07 (0.81-1.42)   1.09 (0.77-1.55)  
Physical disability 0.36 (0.15-0.83) *  0.30 (0.12-0.77) *  0.27 (0.08-0.87) * 
Placement         
    Foster care (ref. Other) 0.42 (0.36-0.50) ***  0.57 (0.47-0.69) ***  2.03 (1.55-2.64) *** 
    Therapeutic FC (ref. Other) 0.26 (0.21-0.32) ***  0.38 (0.29-0.50) ***  1.70 (1.23-2.34) ** 
    Kinship care (ref. Other) 0.64 (0.53-0.78) ***  2.39 (1.94-2.94) ***  3.56 (2.65-4.78) *** 
    Group home (ref. Other) 0.57 (0.49-0.66) ***  0.67 (0.55-0.81) ***  1.57 (1.14-2.18) ** 
Abuse         
    Physical 1.07 (0.77-1.50)   0.95 (0.65-1.39)   1.05 (0.69-1.62)  
    Sex 0.74 (0.52-1.05)   0.69 (0.47-1.00)   0.78 (0.49-1.23)  
    Neglect 0.87 (0.54-1.39)   0.64 (0.39-1.06)   1.34 (0.65-2.76)  
    Other 0.77 (0.46-1.27)   0.51 (0.30-0.88) *  0.81 (0.37-1.77)  
Parents         
    Substance abuse 0.89 (0.71-1.12)   1.20 (0.94-1.53)   1.18 (0.89-1.56)  
    Single parent 0.81 (0.67-0.97) *  1.08 (0.88-1.33)   0.93 (0.73-1.19)  
Entry Cohort 1.07 (1.02-1.12) *  1.06 (1.01-1.12) *  1.09 (1.02-1.16) * 
Number of months in care 0.95 (0.94-0.96) ***  0.96 (0.95-0.97) ***  1.05 (1.04-1.06) *** 
Metropolitan (ref. Rural) 0.89 (0.72-1.09)   0.72 (0.57-0.91) **  1.22 (0.91-1.62)  
Placement changes 0.94 (0.90-0.97) **  0.96 (0.92-1.00) *  0.71 (0.66-0.76) *** 
Note. ADHD = Attention-deficit hyperactivity disorder; FC = Foster care; MH = Mental health; ref. = Reference. 
* p ≤ .05; ** p ≤ .01; *** p ≤ .001 
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Discussion
Major Findings
1. Medicated children stayed in care longer
– Medication is not a quick-fix solution
– Possible delays when medicated:
• Court order mandating mental health treatment 
goals met
• Delays in establishing appropriate specialist6, 7
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Major Findings
2. Placements of medicated children were more 
stable
– Time exposure may be suppressing placement instability 
rates as medicated children tend to be in care longer
– Medicating may address problem behavior that is a risk 
factor of placement disruptions8
– Placement disruptions associated with increased mental 
health need and poor social emotional outcomes9, 10, 11, 
12
– More studies on disruptive behavior on placement 
stabilityD
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Major Findings
3. Medicated children less likely to achieve 
permanency
– Medication treatment modality only 
addresses the child, not their parents
– Meeting needs of parents a greater challenge 
13
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Clinical Relevance
• Medication may help children exit faster in 
the beginning months by stabilizing them 
although does not have this effect in later 
months
• Medicating children may help improve 
placement stability
• Provide a holistic approach to treatment
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Policy Relevance
• Ensure that family services are part of the 
treatment plan in addition to medication 
to help improve exits to permanency
• Facilitate cross-system data sharing
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Limitations and Strengths
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Strengths Limitations
• Large sample size
• Longitudinal
• Human, safe, and non-
intrusive
• Propensity scoring with 
IPTW
• Time-varying covariates
• Causal analysis
• Unobserved confounders
• No behavioral covariates
• Abuse severity unknown
• The tenuous overlap of 
propensity scores may lead 
to imprecise estimates and 
sensitive to misspecification
• Some samples needed to be 
deleted (need larger sample 
size)
Further Considerations and Future Work
• Incorporate time-varying nature of 
treatment (e.g., marginal structural 
modeling)
• Other outcome measures (e.g., health, 
education, juvenile justice, etc.)
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Conclusions
• Medicated children less likely to exit to permanency
• Medicated children in care longer
• Medicated children more stable
• IPTW is promising and viable technique for causal 
analysis involving observational datasets
• Potential to use for other outcomes to determine 
whether care and services help children lead healthy 
and productive lives
Overall Limitations
Administrative Data
Disadvantages
• Variables limited to what is 
collected
• Data quality management
Advantages
• Wealth of data
• Big sample size
• Longitudinal
• Unobtrusive
Overall Limitations
Propensity Score Analysis
Disadvantages
• Assumes there are no 
unmeasured confounders that 
influenced treatment 
assignment
• Requires very large samples
Advantages
• Cheaper and quicker than RCTs
• Study treatments that would 
be infeasible or unethical to 
randomize
• Useful when adjusting for a 
large number of risk factors
Summary
• A substantial percentage of children in foster care are treated 
with psychotropic medication
• Existing literature vary in quality and findings
• Few studies go beyond exploratory research
• Advanced statistics can be applied to large, administrative 
datasets to mimic randomized control trials and help make 
causal inferences
• Cross-systems data provide even more rich information on 
experiences and outcomes of children in foster care
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